TAK-771-4004: Maternal and Infant Characteristics and Outcomes Following Exposure to HyQvia During Pregnancy: A Case Series Study Based on US Claims Data

16/03/2023
23/04/2024
EU PAS number:
EUPAS103800
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

TAK-771-4004-clinical-study-protocol-redact

English (1.21 MB - PDF) View document
Study results
Study results

TAK-771-4004‐clinical‐study‐report‐redact

English (751.29 KB - PDF) View document
Study report
Other information